Position in LH
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$679,840
+$98,195 QoQ
Shares Held
2,428
+11.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#523
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $34,841,755 across 11 Diagnostics & Research names. LH ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
37,709 | $18,905,784 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
8,911 | $4,719,176 | |
| 3 | DHR |
Danaher Corp /De/
|
20,988 | $3,997,794 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,300 | $2,263,692 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
958 | $1,223,854 | |
| 6 | NTRA |
Natera, Inc.
|
3,887 | $1,055,126 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
2,428 | $679,840 | |
| 8 | DGX |
Quest Diagnostics Inc
|
3,169 | $671,669 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $679,840 | 2,428 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $581,645 | 2,180 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $454,594 | 1,812 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $452,119 | 1,575 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $418,178 | 1,593 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $352,368 | 1,514 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $344,667 | 1,503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $355,333 | 1,590 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $365,910 | 1,798 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||